No transmission of SARS-CoV-2 in a patient undergoing allogeneic hematopoietic cell transplantation from a matched-related donor with unknown COVID-19

The Hematology Department and its Hematopoietic Cell Transplantation (HCT) program implemented several measures during COVID-19 outbreak in order to keep clinical activities with the maximum security for both donors and recipients. Nevertheless, there was a lack of evidence whether blood products an...

Descripción completa

Detalles Bibliográficos
Autores principales: Lázaro del Campo, P., de Paz Arias, R., Ramírez López, A., de la Cruz Benito, B., Humala Barbier, K., Sánchez Vadillo, I., López de la Guía, A., de Soto Álvarez, T., Jiménez Yuste, V., Canales Albendea, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444460/
https://www.ncbi.nlm.nih.gov/pubmed/32928663
http://dx.doi.org/10.1016/j.transci.2020.102921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444460/
https://www.ncbi.nlm.nih.gov/pubmed/32928663
http://dx.doi.org/10.1016/j.transci.2020.102921

Ejemplares similares